Logo for Nkarta Inc

Nkarta Investor Relations Material

Latest events

Logo for Nkarta Inc

Status Update

Logo for Nkarta

Corporate Presentation

25 Mar, 2024
Logo for Nkarta

Q4 2023

21 Mar, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Nkarta Inc

Access all reports
Nkarta Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of novel allogeneic, off-the-shelf engineered natural killer (NK) cell therapies for the treatment of cancer. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.